Cellectis S.A.
CLLSNASDAQHealthcare● Active
$2.92
$-0.14(-4.58%)
Market Cap$293217967
P/E Ratio—
52W High$5.48
52W Low$1.327
Cellectis S.A. (CLLS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CLLS · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $72.95M | $41.51M | $0.76M | $19.17M | $30.35M |
| Cost of Revenue | $9.80M | $9.18M | $7.42M | $8.48M | $1.84M |
| Gross Profit | $63.15M | $32.32M | ($6.66M) | $10.69M | $28.50M |
| Gross Margin %(computed) | 86.57% | 77.88% | -882.65% | 55.75% | 93.92% |
| Operating Expenses | |||||
| R&D Expenses | $93.52M | $90.54M | $87.65M | $97.50M | $117.84M |
| G&A Expenses | $8.60M | $8.42M | $8.12M | $8.89M | $37.87M |
| Total Operating Expenses | $96.23M | $91.88M | $90.64M | $100.35M | $131.98M |
| Operating Income | ($33.08M) | ($59.55M) | ($97.30M) | ($89.67M) | ($103.48M) |
| Operating Margin %(computed) | -45.34% | -143.48% | — | -467.72% | -341.00% |
| Interest Income | $9.50M | $11.28M | $3.61M | $1.12M | $0.72M |
| Interest Expense | $8.11M | $7.45M | $5.31M | $3.79M | $4.37M |
| Income Before Tax | ($68.02M) | ($36.76M) | ($116.46M) | ($98.60M) | ($96.75M) |
| Income Tax Expense | ($0.42M) | $0.00M | $0.37M | $0.09M | ($0.00M) |
| Net Income | ($67.59M) | ($36.76M) | ($101.06M) | ($106.14M) | ($114.20M) |
| Net Margin %(computed) | -92.66% | -88.57% | — | -553.64% | -376.32% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.68 | $-0.41 | $-1.77 | $-2.33 | $-1.93 |
| Wtd Avg Shares | 100.28M | 90.57M | 57.01M | 45.55M | 44.82M |
| EBITDA | ($39.85M) | ($9.46M) | ($92.64M) | ($76.38M) | ($78.42M) |
| EBITDA Margin %(computed) | -54.62% | -22.80% | — | -398.40% | -258.44% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Cellectis S.A. data
About Cellectis S.A. (CLLS) Income Statement
Cellectis S.A. (CLLS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CLLS reported revenue of $0.07B, gross profit of $0.06B (gross margin 86.57%), and net income of ($0.07B) — a net profit margin of -92.66%.
Frequently asked questions
CLLS · 4 questionsCellectis S.A. (CLLS) reported revenue of $0.07B for 2025, up 75.8% year-over-year.
CLLS revenueCLLS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08